{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:30:41Z","timestamp":1783413041105,"version":"3.54.6"},"posted":{"date-parts":[[2024,12,16]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":37,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Sub-Saharan Africa (SSA) has the highest sexually transmitted infection (STI) prevalence globally, but information about trends and geographic variation is limited by sparse aetiologic studies, particularly among men. This systematic review assessed chlamydia, gonorrhoea, and trichomoniasis prevalence by sex, sub-region, and year, and estimated male-to-female prevalence ratios for SSA.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched Embase, MEDLINE, Global Health, PubMed, and African Index Medicus for studies measuring STI prevalence among general populations from January 1, 2000, to September 17, 2024. We adjusted observations for diagnostic test performance and used log-binomial mixed-effects meta-regressions to estimate prevalence trends and sex-prevalence ratios.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>Of 5202 records identified, we included 211 studies from 28 countries. In 2020, estimated prevalence among 15-49-year-olds in SSA for chlamydia was 6.6% (95%CI: 5.0-8.2%, n=169 observations) among females and 4.7% (3.4-6.1%, n=33) among males, gonorrhoea was 2.4% (1.4-3.3%, n=171) and 1.7% (0.7-2.6%, n=31), and trichomoniasis was 6.8% (3.6-9.9%, n=188) and 1.7% (0.7-2.7%, n=19). Male-to-female ratio estimates were 0.61 (0.53-0.71) for chlamydia, 0.81 (0.61-1.09) for gonorrhoea, and 0.23 (0.18-0.28) for trichomoniasis. From 2010-2020, chlamydia prevalence increased by 34.5% (11.1-62.9%) in SSA, while gonorrhoea and trichomoniasis trends were not statistically significant. Chlamydia and gonorrhoea prevalence were highest in Southern and Eastern Africa, whereas trichomoniasis was similar across sub-regions.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Interpretation<\/jats:title>\n                  <jats:p>SSA has a high, geographically varied STI burden, with increasing prevalence of chlamydia. Region-specific sex-prevalence ratios differed from existing global ratios and should be considered in future burden estimates. Enhanced sex-stratified surveillance is crucial to guide national programmes and reduce STI prevalence in SSA.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Funding<\/jats:title>\n                  <jats:p>Gates Foundation, Imperial College London, NIH, UKRI<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.12.16.24319070","type":"posted-content","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:03:54Z","timestamp":1734541434000},"source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of chlamydia, gonorrhoea, and trichomoniasis among male and female general populations in sub-Saharan Africa from 2000-2024: A systematic review and meta-regression analysis"],"prefix":"10.64898","author":[{"given":"Julia","family":"Michalow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinton","family":"Hayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Matthew","family":"Chico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olanrewaju","family":"Edun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Kuchukhidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evidence","family":"Majaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domonique M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalene K","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco PH","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Boily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Imai-Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2024122100265982000_2024.12.16.24319070v1.1","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Geneva, 2022."},{"key":"2024122100265982000_2024.12.16.24319070v1.2","unstructured":"World Health Organization. Framework for monitoring sexually transmitted infections and strengthening surveillance. Geneva, 2024."},{"key":"2024122100265982000_2024.12.16.24319070v1.3","unstructured":"World Health Organization. Report on global sexually transmitted infection surveillance. Geneva, 2018."},{"key":"2024122100265982000_2024.12.16.24319070v1.4","unstructured":"Word Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva, 2001."},{"key":"2024122100265982000_2024.12.16.24319070v1.5","unstructured":"World Health Organization. Prevalence and incidence of selected sexually transmitted infections: Methods and results used by WHO to generate 2005 estimates. Geneva, 2011."},{"key":"2024122100265982000_2024.12.16.24319070v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/s0968-8080(12)40660-7"},{"key":"2024122100265982000_2024.12.16.24319070v1.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131080"},{"key":"2024122100265982000_2024.12.16.24319070v1.8","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.228486"},{"key":"2024122100265982000_2024.12.16.24319070v1.9","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections. Web Annex 2: Data methods. Geneva, 2021."},{"key":"2024122100265982000_2024.12.16.24319070v1.10","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"The Lancet"},{"key":"2024122100265982000_2024.12.16.24319070v1.11","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2021-055057"},{"key":"2024122100265982000_2024.12.16.24319070v1.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.3428"},{"key":"2024122100265982000_2024.12.16.24319070v1.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002511"},{"key":"2024122100265982000_2024.12.16.24319070v1.14","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000003163"},{"key":"2024122100265982000_2024.12.16.24319070v1.15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/13625187.2020.1779688","article-title":"Prevalence of Neisseria gonorrhoeae infection among women of reproductive age in sub-Saharan Africa: a systematic review and meta-analysis","volume":"25","year":"2020","journal-title":"The European Journal of Contraception & Reproductive Health Care"},{"key":"2024122100265982000_2024.12.16.24319070v1.16","doi-asserted-by":"crossref","unstructured":"Hussen S , Wachamo D , Yohannes Z , Tadesse E . Prevalence of chlamydia trachomatis infection among reproductive age women in sub Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis 2018; 18. https:\/\/pubmed.ncbi.nlm.nih.gov\/30477441\/ (accessed Sept 4, 2024).","DOI":"10.1186\/s12879-018-3477-y"},{"key":"2024122100265982000_2024.12.16.24319070v1.17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmi.2022.08.008","article-title":"Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis","volume":"29","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2024122100265982000_2024.12.16.24319070v1.18","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000460"},{"key":"2024122100265982000_2024.12.16.24319070v1.19","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05950-x"},{"key":"2024122100265982000_2024.12.16.24319070v1.20","unstructured":"Williams R , Auzenbergs M , Etombi CL , et al. P187. Curable STIs among pregnant women attending antenatal care facilities in low- and middle-income countries from 2000 to 2022: A systematic review and meta-analysis. In: 23rd IUSTI World Congress. 2022."},{"key":"2024122100265982000_2024.12.16.24319070v1.21","unstructured":"UN Statistics Division. Standard country or area codes for statistical use (M49). https:\/\/unstats.un.org\/unsd\/methodology\/m49\/ (accessed June 14, 2023)."},{"key":"2024122100265982000_2024.12.16.24319070v1.22","unstructured":"Covidence systematic review software. Veritas Health Innovation, Melbourne, Australia. https:\/\/www.covidence.org\/ (accessed Dec 2, 2024)."},{"key":"2024122100265982000_2024.12.16.24319070v1.23","doi-asserted-by":"crossref","first-page":"e1004385","DOI":"10.1371\/journal.pmed.1004385","article-title":"Aetiology of vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa: A systematic review and meta-regression","volume":"21","year":"2024","journal-title":"PLoS Med"},{"key":"2024122100265982000_2024.12.16.24319070v1.24","unstructured":"World Health Organization. Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV. Geneva, 2023."},{"key":"2024122100265982000_2024.12.16.24319070v1.25","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","article-title":"Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial","volume":"399","year":"2022","journal-title":"The Lancet"},{"key":"2024122100265982000_2024.12.16.24319070v1.26","unstructured":"UN Population Division. Data Portal. https:\/\/population.un.org\/dataportal\/home (accessed Aug 21, 2023)."},{"key":"2024122100265982000_2024.12.16.24319070v1.27","unstructured":"Hogg R V , McJean JW , Craig AT. Introduction to mathematical statistics, Eighth ed. Boston: Pearson, 2019."},{"key":"2024122100265982000_2024.12.16.24319070v1.28","unstructured":"Stan Development Team. RStan: the R interface to Stan. R package version 2.21.2. 2020. https:\/\/mc-stan.org\/ (accessed May 29, 2023)."},{"key":"2024122100265982000_2024.12.16.24319070v1.29","unstructured":"Generalized linear mixed models using Template Model Builder. R package version 1.1.7. 2023; published online April 5."},{"key":"2024122100265982000_2024.12.16.24319070v1.30","unstructured":"Hall L , Michalow J , Imai-Eaton JW , Boily M-C , Rowley J , Chico M. Sexually transmitted infection prevalence ratios in sub-Saharan Africa: a systematic review and meta-analysis. PROSPERO 2024."},{"key":"2024122100265982000_2024.12.16.24319070v1.31","doi-asserted-by":"crossref","unstructured":"Page MJ , McKenzie JE , Bossuyt PM , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372.","DOI":"10.1136\/bmj.n71"},{"key":"2024122100265982000_2024.12.16.24319070v1.32","unstructured":"Joint United Nations Programme on HIV\/AIDS. IN DANGER: UNAIDS Global AIDS Update. Geneva, 2022."},{"key":"2024122100265982000_2024.12.16.24319070v1.33","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25355"},{"key":"2024122100265982000_2024.12.16.24319070v1.34","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-051005"},{"key":"2024122100265982000_2024.12.16.24319070v1.35","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7001a1"},{"key":"2024122100265982000_2024.12.16.24319070v1.36","first-page":"205863","article-title":"Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017","volume":"13","year":"2018","journal-title":"PLoS One"},{"key":"2024122100265982000_2024.12.16.24319070v1.37","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-052953"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.12.16.24319070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:23:09Z","timestamp":1768508589000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.12.16.24319070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1101\/2024.12.16.24319070","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/j.eclinm.2025.103210","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,12,16]]},"subtype":"preprint"}}